Hinge Health (HNGE) Stock Price, Quote, News & History | Benzinga

SPY761.10−1.39%QQQ707.87−2.77%BTC/USD81,441.37−0.07%DIA518.00−0.59%GLD381.40−0.34%TLT80.06+0.11%

Hinge Health Inc (HNGE) Stock Price, Quote, News & History

HNGENYSE

Trade with Public

Trade with Public

$99.18

-5.78-5.51%

Last update: Oct 16, 7:42 PM

$98.00

-6.96-6.63%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$106.53

Close

$99.18

Volume / Avg.

1.76M / 1.79M

Day Range

$98.00 - $98.00

52 Wk Range

30.08 - 107.00

Market Cap

$8.12B

P/E Ratio

12.77

Dividend Yield

-

Exchange

NYSE

RSI

52

Short Interest

11.76%

Days to Cover

3.33

Recent Hinge Health, Inc. News

Microsoft To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday

Analysts revised targets and ratings for KMX, ARX, JKHY, MRNA, GO, HNGE, AYTU and MSFT, with mixed upgrades, downgrades and reiterations.

Avi Kapoor

Jim Cramer: Buy This Energy Stock, It Is ‘Terrific’

Cramer favored ET, PANW and CRWD over SentinelOne, advised waiting on Corning, called GEMI speculative, and supported holding Aveanna.

Avi Kapoor

Oura Reportedly Eyes $3 Billion IPO at More Than $16 Billion Valuation

Oura Health is preparing for a potential U.S. IPO that could raise up to $3 billion and value the smart ring maker at more than $16 billion.

Caroline Ryan

Jim Cramer Recommends Buying This Health Care Stock: ‘What A Quarter They Had’

Mad Money Lightning Round analysis: Hinge Health a buy after strong quarter, Stellantis not investible, Tractor Supply time to buy, and Cheniere Energy mixed results.

Avi Kapoor

Toast To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Wednesday

Wall Street analysts changed outlook on top names. UBS cut Fidelity National Information target, JP Morgan downgraded Ball, Needham raised Hinge Health.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

290.79M

Investing Cash Flow (TTM)

-19.75M

Financing Cash Flow (TTM)

-222.34M

Free Cash Flow (TTM)

283.92M

Capital Expenditure (TTM)

-6.86M

Net Change in Cash (TTM)

48.69M

Analyst Trends and Forecast

5

Jul

6

Aug

2

1

Sep

2

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$8.09B

PE Ratio (TTM)

12.77

PE Ratio (FWD)

37.59

PEG Ratio (TTM)

-

PS Ratio (TTM)

11.76

PB Ratio (TTM)

24.60

Earnings Yield % (TTM)

7.83%

Earnings Yield % (FWD)

2.66%

EV / EBITDA (TTM)

82.18

Price / EBITDA (TTM)

86.04

Price / Free Cash Flow (TTM)

29.82

Book Value / Share

$4.27

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

$0

LT Debt Repayment (TTM)

-

Total Cash

$286.22M

Debt to Equity

0.02

Issuance of Debt (TTM)

$0

Repayment of Debt (TTM)

-